Abstract:Background: A carrying structure for targeted transdermal drug delivery is a transferosome. These unique liposomes are made of an edge activator and phosphatidylcholine. The most common antiviral drug is acyclovir, a synthetic nucleotide nucleoside analog derived from guanine. It works well to cure the varicella-zoster virus and the virus that causes herpes simplex (HSV), primarily HSV-1 and HSV-2. But its skin permeability is minimal. Therefore, this work aimed to use transferosomes to prepare acyclovir so that it could pass through the skin's barrier function. Objective: This study uses a 3 2 -factorial factorial design to develop a transferosomal gel containing acyclovir through thin-film hydration method for painless acyclovir delivery services for skin disease treatment. Material and Methods: The independent variables are the amount of phospholipid (X 1 ) and tween 80 (X 2 ), while the dependent variables are particle size (Y 1 ) and percentage entrapment efficiency (Y 2 ). To create an ideal formulation, the produced transferosomes were assessed for particle size, in vitro drug release amount, and entrapment efficiency (EE%). A Carbopol 934 gel basis was prepared using the optimized acyclovir transferosome formulation, and its drug concentration, pH, spreadability, viscosity, and stability were assessed. Results: With small particles ranging from 176.6 to 324.4 nm, the produced acyclovir transferosomes had a high EE% range from 66.34 to 76.42 %. According to the in vitro release study, there is a negative correlation between in vitro release and EE%. The formulation TF5, including 1%w/w of carbopol 940, provides a superior profile of drug absorption in vitro. Consequently, acyclovir can enter the skin as transferosomes and cross the stratum corneum barrier. Conclusion: Acyclovir can be transformed into a transfersomal gel, which will improve antiviral efficacy, get over the skin's protective layer, prevent adverse oral reactions, and eventually improve patient adherence. Keywords: Transferosome, Transdermal drug delivery system, Acyclovir, 3 2 Fractional factorial design, Carbopol 934

The Effect of Amphiphilic N,N,N-trimethyl-O-octadecyl Chitosan on the Oral Bioavailability of Acyclovir

Determination of Apparent Drug Permeability Coefficients Through Chitosan-Sodium Cellulose Sulfate Polyelectrolyte Complex Films

Changes in pelvic muscle tissues associated with hip dysplasia in dogs.

Development of Mucoadhesive Microspheres of Acyclovir with Enhanced Bioavailability.

Development and evaluation of acyclovir loaded chitosan microspheres and cross linked with glutaraldehyde

Combined use of bile acids and aminoacids to improve permeation properties of acyclovir

Synthesis and Anti-Hepatitis B Virus Activity of Acyclovir Conjugated Stearic Acid-G-chitosan Oligosaccharide Micelle

In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers

Oral Pharmacokinetics of a Chitosan-Based Nano- Drug Delivery System of Interferon Alpha

The bioadhesive property of aciclovir microspheres on animal's gastric mucin and its in vitro effect of sustained drug release

Feasibility of Enhancing Skin Permeability of Acyclovir through Sterile Topical Lyophilized Wafer on Self-Dissolving Microneedle-Treated Skin

Chitosan/Xanthan Gum Based Hydrogels as Potential Carrier for an Antiviral Drug: Fabrication, Characterization, and Safety Evaluation

Effect of Acyclovir Solid Lipid Nanoparticles for the Treatment of Herpes Simplex Virus (HSV) Infection in an Animal Model of HSV-1 Infection

Formulation and optimization of microsponge-loaded emulgel to improve the transdermal application of acyclovir—a DOE based approach

Separation and isolation of fusion protein using a new native preparative PAGE device.

Characteristics of bombesin-induced inhibition of intake of ethanol

Bioavailability Enhancement of Glucosamine Hydrochloride by Chitosan.

Formulation and Evaluation of Acyclovir Loaded Transferosomal Gel for Transdermal Drug Delivery

Stearic Acid-G-chitosan Polymeric Micelle for Oral Drug Delivery: in Vitro Transport and in Vivo Absorption.

Preparation and Optimization of Amorphous Ursodeoxycholic Acid Nanosuspensions by Nanoprecipitation based on Acid-base Neutralization for Enhanced Dissolution.

Simultaneous Improvement of Dissolution Behavior and Oral Bioavailability of Antifungal Miconazole via Cocrystal and Salt Formation